---
title: "Therapeutic patient education reduces one-year major cardiovascular events in Tunisian CHD cohort"
id: "plos-one-3-evaluation-of-a-therapeutic-education-program-for-patients-with-coronary-heart"
canonical_url: "https://medichelpline.com/clinical-feed/plos-one-3-evaluation-of-a-therapeutic-education-program-for-patients-with-coronary-heart"
content_type: "clinical_feed_article"
specialty: "Cardiology"
source_name: "PLOS ONE (Medicine)"
source_url: "https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0361814"
published_at: "2026-11-09T14:00:00.000Z"
evidence_level: "Journal Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Therapeutic patient education reduces one-year major cardiovascular events in Tunisian CHD cohort
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/plos-one-3-evaluation-of-a-therapeutic-education-program-for-patients-with-coronary-heart
- **Specialty:** [Cardiology](https://medichelpline.com/clinical-feed/cardiology.md)
- **Primary Source:** PLOS ONE (Medicine)
- **Source URL:** [Original Journal Publication](https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0361814)
- **Published At:** 2026-11-09T14:00:00.000Z
- **Evidence Rating:** Journal Feed
## Executive GIST (TL;DR)
- A quasi-experimental study in Sahloul University Hospital enrolled 129 adults with documented **coronary heart disease** and followed them for one year; recruitment occurred May 2022 with consecutive sampling. - The intervention arm (n = 38) received a four-stage **therapeutic patient education (TPE)** program; the control arm (n = 91) received standard care and met identical inclusion and exclusion criteria. - Primary endpoint was the occurrence of major cardiovascular events at one year; secondary endpoints included patient knowledge, lipid profile, glycated hemoglobin, and quality of life. - Investigators reported a lower rate of major cardiovascular events in the TPE group versus control (21.1% vs. 59.3%, p < 0.001). - Knowledge of cardiovascular risk factors rose immediately after the intervention (71.1% to 78.9%, p = 0.039) with about 60.5% retention at three months. - Lipid parameters improved in the TPE arm: mean **LDL cholesterol** fell from 2.53 ± 1.45 to 1.88 ± 1.11 mmol/L at three months (p < 0.001); total cholesterol also decreased (4.32 ± 1.47 to 3.75 ± 1.56 mmol/L, p = 0.002). - The control group showed worsening lipids over three months (LDL from 2.50 ± 1.55 to 2.90 ± 1.60 mmol/L, p = 0.001). - The study was prospectively registered (PACTR202307694422939); data supporting analyses are provided as supporting information with the paper. - The authors acknowledged the quasi-experimental single-center design and the recruitment approach as study limitations; the source did not report further details on TPE curriculum content, session frequency, or long-term adherence beyond three months for biological measures.
## Clinical Analysis & Structured Key Points
[ Skip to main content ](https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0361814#main-content) Advertisement * [plos.org](https://plos.org/) * [Create account](https://community.plos.org/registration/new) * [Sign in](https://journals.plos.org/user/secure/login?page=%2Fplosone%2Farticle%3Fid%3D10.1371%2Fjournal.pone.0361814) * * About * Browse * Publish * [](https://journals.plos.org/plosone/ "PLOS One") * Search [advanced search](https://journals.plos.org/plosone/search) * [Browse Topics](https://journals.plos.org/plosone/subjectAreaBrowse) Browse Subject Areas ? Click through the PLOS taxonomy to find articles in your field. For more information about PLOS Subject Areas, click [here](https://github.com/PLOS/plos-thesaurus/blob/master/README.md "Link opens in new window"). [](https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0361814) [](https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0361814) * 0 [Save](https://journals.plos.org/plosone/article/metrics?id=10.1371/journal.pone.0361814#savedHeader) [Total Mendeley and Citeulike bookmarks.](https://journals.plos.org/plosone/article/metrics?id=10.1371/journal.pone.0361814#savedHeader) * 0 [Citation](https://journals.plos.org/plosone/article/metrics?id=10.1371/journal.pone.0361814#citedHeader) [Paper's citation count computed by Dimensions.](https://journals.plos.org/plosone/article/metrics?id=10.1371/journal.pone.0361814#citedHeader) * 21 [View](https://journals.plos.org/plosone/article/metrics?id=10.1371/journal.pone.0361814#viewedHeader) [PLOS views and downloads.](https://journals.plos.org/plosone/article/metrics?id=10.1371/journal.pone.0361814#viewedHeader) * 0 [Share](https://journals.plos.org/plosone/article/metrics?id=10.1371/journal.pone.0361814#discussedHeader) [Sum of Facebook, Twitter, Reddit and Wikipedia activity.](https://journals.plos.org/plosone/article/metrics?id=10.1371/journal.pone.0361814#discussedHeader) Open Access Peer-reviewed Research Article # Evaluation of a therapeutic education program for patients with coronary heart disease in a Tunisian university hospital: A quasi-experimental study * Hela Ghali , Contributed equally to this work with: Hela Ghali, Mohamed Ayoub Tlili, Aymen El Hraiech, Chekib Zedini Roles Conceptualization, Data curation, Formal analysis, Methodology, Validation, Writing – original draft, Writing – review & editing * E-mail: hela.ghali@outlook.com Affiliations Department of Preventive and Community Medicine, Sahloul University Hospital, Sousse, Tunisia, Faculty of Medicine of Sousse, University of Sousse, Sousse, Tunisia [ ![ORCID logo](https://journals.plos.org/resource/img/orcid_16x16.png) https://orcid.org/0000-0001-5330-9069 ](https://orcid.org/0000-0001-5330-9069 "ORCID Registry") ⨯ * Mohamed Ayoub Tlili , Contributed equally to this work with: Hela Ghali, Mohamed Ayoub Tlili, Aymen El Hraiech, Chekib Zedini Roles Data curation, Formal analysis, Validation, Writing – review & editing Affiliation Nursing Administration Department, College of Nursing, University of Hail, Hail, Saudi Arabia ⨯ * Aymen El Hraiech , Contributed equally to this work with: Hela Ghali, Mohamed Ayoub Tlili, Aymen El Hraiech, Chekib Zedini Roles Conceptualization, Data curation, Formal analysis, Writing – review & editing Affiliations Faculty of Medicine of Sousse, University of Sousse, Sousse, Tunisia, Department of Cardiology, Sahloul University Hospital, Sousse, Tunisia ⨯ * Jihen Sahli , Roles Data curation, Methodology, Validation, Writing – review & editing ¶‡ These authors also contributed equally to this work. Affiliations Faculty of Medicine of Sousse, University of Sousse, Sousse, Tunisia, Department of Family and Community Medicine, Sousse, Tunisia ⨯ * Sana Bhiri , Roles Data curation, Methodology, Validation, Writing – review & editing ¶‡ These authors also contributed equally to this work. Affiliations Department of Preventive and Community Medicine, Sahloul University Hospital, Sousse, Tunisia, Faculty of Medicine of Sousse, University of Sousse, Sousse, Tunisia ⨯ * Saoussen Layouni , Roles Data curation, Methodology, Validation, Writing – review & editing ¶‡ These authors also contributed equally to this work. Affiliations Faculty of Medicine of Sousse, University of Sousse, Sousse, Tunisia, Department of Physical Rehabilitation, Sahloul University Hospital, Sousse, Tunisia ⨯ * Hend Ben Souda , Roles Data curation, Investigation, Validation, Writing – review & editing ¶‡ These authors also contributed equally to this work. Affiliation Family Medicine, Faculty of Medicine of Sousse, University of Sousse, Sousse, Tunisia ⨯ * Majdi Karray , Roles Data curation, Methodology, Software, Writing – review & editing ¶‡ These authors also contributed equally to this work. Affiliation Faculty of Pharmacy of Monastir, University of Monastir, Monastir, Tunisia ⨯ * Bruno Pavy , Roles Data curation, Methodology, Supervision, Writing – review & editing ¶‡ These authors also contributed equally to this work. Affiliation Cardiac Rehabilitation Department, Loire-Vendée-Océan Hospital Center, Machecoul, France ⨯ * Asma Ben Cheikh , Roles Data curation, Methodology, Supervision, Writing – review & editing ¶‡ These authors also contributed equally to this work. Affiliations Department of Preventive and Community Medicine, Sahloul University Hospital, Sousse, Tunisia, Faculty of Medicine of Sousse, University of Sousse, Sousse, Tunisia ⨯ * Chekib Zedini Contributed equally to this work with: Hela Ghali, Mohamed Ayoub Tlili, Aymen El Hraiech, Chekib Zedini Roles Data curation, Methodology, Supervision, Writing – review & editing Affiliations Faculty of Medicine of Sousse, University of Sousse, Sousse, Tunisia, Department of Family and Community Medicine, Sousse, Tunisia ⨯ # Evaluation of a therapeutic education program for patients with coronary heart disease in a Tunisian university hospital: A quasi-experimental study * Hela Ghali, * Mohamed Ayoub Tlili, * Aymen El Hraiech, * Jihen Sahli, * Sana Bhiri, * Saoussen Layouni, * Hend Ben Souda, * Majdi Karray, … * Bruno Pavy, * Asma Ben Cheikh ![PLOS](https://journals.plos.org/resource/img/logo-plos-full-color.svg) x * Published: November 9, 2026 * * [Article](https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0361814) * [Authors](https://journals.plos.org/plosone/article/authors?id=10.1371/journal.pone.0361814) * [Metrics](https://journals.plos.org/plosone/article/metrics?id=10.1371/journal.pone.0361814) * [Comments](https://journals.plos.org/plosone/article/comments?id=10.1371/journal.pone.0361814) * [Media Coverage](http://plos.altmetric.com/details/doi/10.1371/journal.pone.0361814) * [Abstract](https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0361814#abstract0) * [Introduction](https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0361814#sec006) * [Methods](https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0361814#sec007) * [Results](https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0361814#sec018) * [Discussion](https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0361814#sec028) * [Conclusion](https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0361814#sec030) * [Supporting information](https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0361814#sec031) * [References](https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0361814#references) * [Reader Comments](https://journals.plos.org/plosone/article/comments?id=10.1371/journal.pone.0361814) * [Figures](https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0361814) ## Abstract ### Background Cardiovascular disease (CVD) is a major public health concern globally, including Tunisia. Therapeutic Patient Education (TPE) plays a crucial role in managing CVD and improving patient outcomes. This study aimed to evaluate the impact of a TPE program on the occurrence of major cardiovascular events in patients with coronary heart disease (CHD) in a Tunisian university hospital. ### Methods A quasi-experimental study was conducted over one year, involving 129 patients with CHD. The intervention group (n = 38) received a four-stage TPE program, while the control group (n = 91) received standard care. The control group met the same inclusion and non-inclusion criteria as the intervention group. It was constituted based on a 3:1 ratio. Patients in the intervention and control groups were recruited from the same department and during the same period to ensure comparability. The primary outcome was the occurrence of major cardiovascular events within one year. Secondary outcomes included knowledge, lipid profile, glycated hemoglobin levels, and quality of life. ### Results The occurrence of major cardiovascular events was significantly lower in the intervention group compared to the control group (21.1% vs. 59.3%, p < 0.001). The TPE program was also associated with improvements in knowledge and biological parameters. Knowledge of cardiovascular risk factors increased from 71.1% at baseline to 78.9% immediately post-intervention (p = 0.039), with 60.5% retention at 3 months. The intervention group showed marked improvements in lipid profiles, with LDL cholesterol decreasing from 2.53 ± 1.45 to 1.88 ± 1.11 mmol/L (p < 0.001) and total cholesterol from 4.32 ± 1.47 to 3.75 ± 1.56 mmol/L (p = 0.002) at 3 months. In contrast, the control group demonstrated worsening lipid parameters (LDL: 2.50 ± 1.55 to 2.90 ± 1.60 mmol/L, p = 0.001). ### Conclusions The TPE program was associated with a lower occurrence of major cardiovascular events and improvements in patients’ knowledge and lipid profiles. These findings suggest a potential beneficial effect of structured therapeutic education in patients with CHD. ### Trial registration The study was prospectively registered on the Pan African Clinical Trial Registry within the number [PACTR202307694422939](https://clinicaltrials.gov/ct2/show/PACTR202307694422939). The authors confirm that all ongoing and related trials for this intervention are registered. ## Figures ![Table 5](https://journals.plos.org/plosone/article/figure/image?size=inline&id=10.1371/journal.pone.0361814.t005) ![Table 6](https://journals.plos.org/plosone/article/figure/image?size=inline&id=10.1371/journal.pone.0361814.t006) ![Fig 1](https://journals.plos.org/plosone/article/figure/image?size=inline&id=10.1371/journal.pone.0361814.g001) ![Fig 2](https://journals.plos.org/plosone/article/figure/image?size=inline&id=10.1371/journal.pone.0361814.g002) ![Table 1](https://journals.plos.org/plosone/article/figure/image?size=inline&id=10.1371/journal.pone.0361814.t001) ![Table 2](https://journals.plos.org/plosone/article/figure/image?size=inline&id=10.1371/journal.pone.0361814.t002) ![Table 3](https://journals.plos.org/plosone/article/figure/image?size=inline&id=10.1371/journal.pone.0361814.t003) ![Table 4](https://journals.plos.org/plosone/article/figure/image?size=inline&id=10.1371/journal.pone.0361814.t004) ![Table 5](https://journals.plos.org/plosone/article/figure/image?size=inline&id=10.1371/journal.pone.0361814.t005) ![Table 6](https://journals.plos.org/plosone/article/figure/image?size=inline&id=10.1371/journal.pone.0361814.t006) ![Fig 1](https://journals.plos.org/plosone/article/figure/image?size=inline&id=10.1371/journal.pone.0361814.g001) ![Fig 2](https://journals.plos.org/plosone/article/figure/image?size=inline&id=10.1371/journal.pone.0361814.g002) ![Table 1](https://journals.plos.org/plosone/article/figure/image?size=inline&id=10.1371/journal.pone.0361814.t001) **Citation:** Ghali H, Tlili MA, El Hraiech A, Sahli J, Bhiri S, Layouni S, et al. (2026) Evaluation of a therapeutic education program for patients with coronary heart disease in a Tunisian university hospital: A quasi-experimental study. PLoS One 21(11): e0361814. https://doi.org/10.1371/journal.pone.0361814 **Editor:** Kamal Sharma, UN Mehta Institute of Cardiology and Research Center, INDIA **Received:** July 12, 2025; **Accepted:** October 15, 2026; **Published:** November 9, 2026 **Copyright:** © 2026 Ghali et al. This is an open access article distributed under the terms of the [Creative Commons Attribution License](http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. **Data Availability:** The dataset is uploaded as [Supporting information](https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0361814#sec031) with our paper. **Funding:** The author(s) received no specific funding for this work. **Competing interests:** The authors have declared that no competing interests exist. ## Introduction Cardiovascular diseases (CVD), including coronary heart disease (CHD), hypertension, stroke, and congenital heart defects, remain a leading cause of morbidity and mortality worldwide [[1](https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0361814#pone.0361814.ref001)]. Risk factors such as smoking, unhealthy diet, physical inactivity, and stress contribute significantly to their development. With the global prevalence of CVD rising, there is an increasing need for effective strategies to predict and prevent cardiovascular events [[1](https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0361814#pone.0361814.ref001)–[3](https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0361814#pone.0361814.ref003)]. CHD alone affected 154 million people in 2016, accounting for 32.7% of the global cardiovascular disease burden [[4](https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0361814#pone.0361814.ref004)]. In adults over 20 years, nearly half have some form of CVD [[5](https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0361814#pone.0361814.ref005)]. In the Middle East and North Africa, the burden remains particularly high [[6](https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0361814#pone.0361814.ref006)]. Specifically in Tunisia, CHD-related mortality increased by 30% between 1997 and 2009, with ischemic heart disease causing 176.5 deaths per 100,000 inhabitants in 2019 [[6](https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0361814#pone.0361814.ref006),[7](https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0361814#pone.0361814.ref007)]. This is largely driven by high rates of cardiovascular risk factors, including hypertension (50.4%), dyslipidemia (44%), obesity (31.4%), smoking (24.4%), and diabetes (18.2%) in 2020 [[8](https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0361814#pone.0361814.ref008),[9](https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0361814#pone.0361814.ref009)]. Effective management of these risk factors, alongside pharmacological and interventional therapies, is essential to reduce recurrent hospitalizations, cardiovascular complications, and healthcare costs [[10](https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0361814#pone.0361814.ref010)–[12](https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0361814#pone.0361814.ref012)]. Therapeutic patient education (TPE) has emerged as a key non-pharmacological intervention, empowering patients with the knowledge and skills to manage chronic diseases, improve adherence, and enhance quality of life (QoL) [[13](https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0361814#pone.0361814.ref013)]. Evidence shows that educated patients achieve better disease control, fewer complications, and improved outcomes [[14](https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0361814#pone.0361814.ref014),[15](https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0361814#pone.0361814.ref015)]. In CHD, TPE supports risk factor control, treatment adherence, and patient confidence, ultimately promoting better prognosis. However, despite its demonstrated benefits in chronic diseases, there is limited evidence on the effectiveness of structured TPE programs specifically targeting patients with coronary heart disease in low- and middle-income countries, particularly in North Africa. Few studies have explored its long-term impact on cardiovascular outcomes, such as the reduction of major cardiovascular events or the maintenance of improved risk factor control over time [[11](https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0361814#pone.0361814.ref011)–[13](https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0361814#pone.0361814.ref013)]. Therefore, this study aimed to evaluate the effectiveness of a structured TPE program in improving knowledge and QoL, controlling lipid parameters, and reducing the occurrence of major cardiovascular events among patients with CHD. ## Methods ### Study design and setting This is a quasi-experimental study ([Figs 1](https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0361814#pone-0361814-g001)–[2](https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0361814#pone-0361814-g002)) conducted in the cardiology department of Sahloul University Hospital (Sousse, Tunisia) between May 2022 and August 2023. The design was selected to evaluate the TPE program under real-world clinical conditions. [![thumbnail](https://journals.plos.org/plosone/article/figure/image?size=inline&id=10.1371/journal.pone.0361814.g001)](https://journals.plos.org/plosone/article/figure/image?size=medium&id=10.1371/journal.pone.0361814.g001 "Click for larger image") Download: * [PNG larger image](https://journals.plos.org/plosone/article/figure/image?download&size=large&id=10.1371/journal.pone.0361814.g001) * [TIFF original image](https://journals.plos.org/plosone/article/figure/image?download&size=original&id=10.1371/journal.pone.0361814.g001) Fig 1. CONSORT flowchart. [ https://doi.org/10.1371/journal.pone.0361814.g001](https://doi.org/10.1371/journal.pone.0361814.g001) [![thumbnail](https://journals.plos.org/plosone/article/figure/image?size=inline&id=10.1371/journal.pone.0361814.g002)](https://journals.plos.org/plosone/article/figure/image?size=medium&id=10.1371/journal.pone.0361814.g002 "Click for larger image") Download: * [PNG larger image](https://journals.plos.org/plosone/article/figure/image?download&size=large&id=10.1371/journal.pone.0361814.g002) * [TIFF original image](https://journals.plos.org/plosone/article/figure/image?download&size=original&id=10.1371/journal.pone.0361814.g002) Fig 2. Study timeline. [ https://doi.org/10.1371/journal.pone.0361814.g002](https://doi.org/10.1371/journal.pone.0361814.g002) ### Study population and sample size calculation Participants were consecutively recruited between May 1 and May 31, 2022, and were followed for one year. Eligible patients were adults aged 18 years or older with documented coronary heart disease, either revascularized or awaiting revascularization. The study excluded patients who had substantial cognitive impairment, were hospitalized for non-coronary diseases, or declined to participate in the TPE program. To reduce selection bias, patients in both the intervention and control groups were recruited from the same department, during the same period, and according to identical inclusion and non-inclusion criteria. Inclusion in the intervention group required informed consent. Patients who declined participation were not included in the study and were not reassigned to the control group. The sample size was calculated based on parameters reported by Anderson et al. (2017) [[16](https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0361814#pone.0361814.ref016
## Related Clinical Research

- [Fewer than 5% of U.S. Veterans Achieve Optimal Heart Health, AHA Reports](https://medichelpline.com/clinical-feed/aha-news-1-menos-del-5-de-los-veteranos-militares-estadounidenses-podr-an-alcanzar-un.md)
- [Challenges in Blood Pressure Management Post-Stroke and Diabetes](https://medichelpline.com/clinical-feed/stat-news-0-lowering-blood-pressure-after-stroke-or-with-diabetes-poses-challenges-in.md)
- [ZEUS trial: IL-6 blocker ziltivekimab lowered inflammation but did not cut major CV events](https://medichelpline.com/clinical-feed/aha-news-1-researchers-say-inflammation-as-a-treatment-target-still-important-despite.md)
- [Comparing BMI, Waist Circumference, and BRI for Predicting ASCVD, AF, and Mortality in 1.2M Koreans](https://medichelpline.com/clinical-feed/plos-one-14-prognostic-associations-of-anthropometric-indices-with-major-health-outcomes-a.md)
- [Stroke and Ischemic Heart Disease Trends in Western Sub‑Saharan Africa vs Global Progress, 1990–20](https://medichelpline.com/clinical-feed/medrxiv-0-divergent-trends-in-stroke-and-ischemic-heart-disease-mortality-and-disability.md)

## Navigation
- [← Back to Cardiology Feed](https://medichelpline.com/clinical-feed/cardiology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.